Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase

Outstanding results have been obtained in the treatment of chronic myeloid leukemia (CML) with first-line imatinib therapy. However, approximately 35% of patients will not obtain long-term benefit with this approach. Allogeneic hematopoietic stem cell transplantation (HCT) is a valuable second- and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood
Hoofdauteurs: Pavlů, Jiří, Kew, Andrea K., Taylor-Roberts, Beatrice, Auner, Holger W., Marin, David, Olavarria, Eduardo, Kanfer, Edward J., MacDonald, Donald H., Milojkovic, Dragana, Rahemtulla, Amin, Rezvani, Katayoun, Goldman, John M., Apperley, Jane F., Szydlo, Richard M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2010
Onderwerpen:
Clinical Trials and Observations
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143151/
https://ncbi.nlm.nih.gov/pubmed/20304808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-01-263624
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items